Benchmarking:
Are You Billing Bronchodilator Nebulizer Medication More Than Others?
Published on Tue Feb 07, 2023
Remember that a CBR is an educational tool. A recent comparative billing report (CBR), compiled by RELI Group Inc., examined the payment rates of bronchodilator nebulizer medications for Medicare Part B beneficiaries. From 2021 to 2022, the analysis team looked at providers’ reimbursement rates for different medication categories and how the paid claims stacked up against national and specialty averages. [...]